SIMBRINZA is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Brinzolamide; Brimonidine Tartrate.
Product ID | 0065-4147_3f6a7e6a-1383-4eda-8d2a-a167cb98c9e6 |
NDC | 0065-4147 |
Product Type | Human Prescription Drug |
Proprietary Name | SIMBRINZA |
Generic Name | Brinzolamide/brimonidine Tartrate |
Dosage Form | Suspension/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2013-05-01 |
Marketing Category | NDA / NDA |
Application Number | NDA204251 |
Labeler Name | Alcon Laboratories, Inc. |
Substance Name | BRINZOLAMIDE; BRIMONIDINE TARTRATE |
Active Ingredient Strength | 10 mg/mL; mg/mL |
Pharm Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2013-05-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204251 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2013-05-01 |
Marketing Category | NDA |
Application Number | NDA204251 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-05-01 |
Ingredient | Strength |
---|---|
BRINZOLAMIDE | 10 mg/mL |
SPL SET ID: | a49c157e-6310-0011-7b7f-e26fc1820d59 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0065-4147 | SIMBRINZA | brinzolamide/brimonidine tartrate |
0078-0904 | SIMBRINZA | brinzolamide/brimonidine tartrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SIMBRINZA 85306875 4388553 Live/Registered |
Novartis AG 2011-04-28 |